JAMA summit report outlines multilevel strategy for obesity care and prevention

A JAMA summit report highlights that while GLP-1 receptor agonists offer new opportunities, curbing obesity requires addressing broad structural, societal, and clinical barriers. Obesity affects more than 1 billion people worldwide, including nearly half of US adults and 1 in 5 US children. Existing prevention measures have had inadequate impact, while clinical management faces ongoing challenges with access, cost, tolerability, and chronicity of use. The authors state that no single intervention is sufficient, calling for coordinated actions across policy, health systems, and research alongside pharmacological therapies. Online version: https://www.diabesityrounds.com/a/jama-summit-report-outlines-multilevel-strategy-for-obesity-care-and-prevention

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-11-18
DOI
https://doi.org/10.5281/zenodo.24361223
Primary Topic
Pharmacology and Obesity Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

JAMA summit report outlines multilevel strategy for obesity care and prevention

Diabesity Rounds
Zenodo (CERN European Organization for Nuclear Research)
Pharmacology and Obesity Treatment
article

JAMA summit report outlines multilevel strategy for obesity care and prevention

Diabesity Rounds
article en

Abstract

A JAMA summit report highlights that while GLP-1 receptor agonists offer new opportunities, curbing obesity requires addressing broad structural, societal, and clinical barriers. Obesity affects more than 1 billion people worldwide, including nearly half of US adults and 1 in 5 US children. Existing prevention measures have had inadequate impact, while clinical management faces ongoing challenges with access, cost, tolerability, and chronicity of use. The authors state that no single intervention is sufficient, calling for coordinated actions across policy, health systems, and research alongside pharmacological therapies. Online version: https://www.diabesityrounds.com/a/jama-summit-report-outlines-multilevel-strategy-for-obesity-care-and-prevention

Zenodo (CERN European Organization for Nuclear Research)
Pharmacology and Obesity Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon